Emcure Pharmaceuticals is a leading Indian pharmaceutical company that was founded in 1981. The company has a strong presence in the domestic market and also exports to more than 70 countries worldwide. Emcure Pharmaceuticals offers a wide range of products including formulations, active pharmaceutical ingredients (APIs), and biosimilars. Emcure indusry is the best precticle example of Pharma Industry 4.0. 
- Corporate Head Quater
- Emcure Hinjawadi Campus
- Address: Plot P-II, IT-BT Park, M.I.D.C., Hinjawadi, Pune- 411 057
- Total manufacturing Units: 14 numbers
- Total Research and development Centres: 5 Nos
- Total Numbers of brands Product: approx. 350 Plus
Emcure Pharmaceutical 600 is likely a reference to one of the company’s products, but without further context it is difficult to provide specific information. However, the company’s product portfolio includes medications for various therapeutic areas such as oncology, cardiology, neurology, and respiratory diseases. Emcure Pharmaceutical has a strong focus on research and development, and invests a significant amount of resources into developing new and innovative products.
Emcure Pharmaceutical has received numerous awards and accolades for its contributions to the pharmaceutical industry. The company has a strong commitment to quality and compliance, and has been certified by various regulatory agencies including the US FDA, UK MHRA, and WHO. Overall, Emcure Pharmaceuticals is a respected and well-established player in the Indian pharmaceutical market and has a growing global presence.
Emcure Pharmaceuticals Ltd Headquarters
- Phase 1, Rajiv Gandhi IT Park, MIDC, Hinjewadi, Pune, Maharashtra, 411057
emcure pharmaceuticals ltd plant and locations:
As of my knowledge cutoff date of September 2021, Emcure Pharmaceutical had six manufacturing facilities located in India. The locations of these facilities are as follows:
1. Emcure Pharmaceuticals Limited Hinjwadi, Pune,
- Solid Dosage facility
- Phase, 2, MIDC, ITBT Park, Pimpri-Chinchwad, Maharashtra 411057
- Approvals received: EU – EMA, Health Canada, ANVISA, cGMP India
2. Injectables, Sanand
- Sanand GIDC Gate no -II, Sanand, Gujarat 382110
Approvals received: USFDA, EU – EMA, Health Canada, cGMP Ind
3. Orals, Kadu
4. Kurkumbh, Pune, Maharashtra
5. Sikkim Plant
- Zuventus Healthcare Ltd.
- 6HP8, Sikkim 737132
6. Orals, Jammu- Plant 1 , Orals, Jammu- Plant 2
- SIDCO INDUSTRIAL COMPLEX Lane No. 3, Phase-II Bari Brahmana, Jammu, 181133
- Approvals received: cGMP India, Philippines, Thailand, NAFDAC Nigeria, various ROW
7. Orals, Bengaluru
8. Orals, Mehsana
These facilities are equipped with modern manufacturing technologies and adhere to strict quality standards to ensure that the products manufactured by Emcure Pharmaceuticals are safe, effective, and of high quality. It is important to note that companies may expand or modify their facilities over time, so it is possible that the number or locations of Emcure Pharmaceuticals’ manufacturing plants may have changed since my knowledge cutoff date.
emcure pharmaceuticals valuation, carrier growth and work culture:
Emcure Pharmaceuticals offers various career opportunities for individuals in different fields such as research and development, manufacturing, sales, marketing, quality control, regulatory affairs, and more. The company provides its employees with a challenging and dynamic work environment and offers opportunities for professional development and growth.
Emcure Pharmaceutical encourages its employees to enhance their skills and knowledge through various training and development programs. The company also provides opportunities for employees to work on cross-functional projects and take on leadership roles. Performance-based incentives and rewards are also offered to motivate and recognize the contributions of employees.
The company has a well-defined career progression framework that enables employees to move up the ladder based on their skills, experience, and performance. Emcure Pharmaceuticals also has a policy of promoting from within the organization, which provides opportunities for career advancement and growth.
Overall, Emcure Pharmaceutical is known for providing its employees with a challenging and rewarding work environment and opportunities for career development and growth.
You may also read about:
emcure pharmaceuticals founder
emcure pharmaceuticals owner
Emcure Pharmaceuticals was founded by Mr. Satish Mehta in 1981. Satish Mehta is a well-known entrepreneur and philanthropist who has made significant contributions to the pharmaceutical industry in India. He has led Emcure Pharmaceuticals to become one of the leading pharmaceutical companies in India, with a strong focus on research and development and a commitment to providing high-quality and affordable healthcare products to people around the world.
Under the leadership of Satish Mehta, Emcure Pharmaceutical has grown rapidly over the years, expanding its product portfolio and global presence. The company has received numerous awards and accolades for its contributions to the pharmaceutical industry and its commitment to corporate social responsibility. Today, Emcure Pharmaceuticals is a respected and well-established player in the Indian pharmaceutical market, with a growing global footprint.
emcure pharmaceuticals subsidiaries
As of my knowledge cutoff date of September 2021, Emcure Pharmaceutical had several subsidiaries operating in different parts of the world. These subsidiaries are:
- Gennova Biopharmaceuticals Limited
- Zuventus Healthcare Limited
- Emcure Pharmaceutical USA Inc. – based in New Jersey, USA
- Emcure Pharmaceutical UK Limited – based in London, UK
- Marcan Pharmaceuticals Inc., Canada
- Bharadwaj Pharma GMBH in Germany
- Emcure Pharmaceutical Australia Pty Ltd – based in Melbourne, Australia
- Heritage Pharmaceutical Inc. – based in New Jersey, USA
- Zao Emcure Pharma – based in Russia
- Global Pharmatech Pvt. Ltd. – based in India
These subsidiaries operate in different capacities, such as manufacturing, distribution, and marketing of Emcure Pharmaceuticals’ products in various regions around the world. It is important to note that companies may expand or modify their subsidiaries over time, so it is possible that the number or locations of Emcure Pharmaceuticals’ subsidiaries may have changed since my knowledge cutoff date.
emcure pharmaceuticals products
Emcure Pharmaceutical offers a wide range of products including formulations, active pharmaceutical ingredients (APIs), and biosimilars. The company’s product portfolio covers various therapeutic areas such as oncology, cardiology, neurology, respiratory diseases, gastroenterology, and more. Some of the products offered by Emcure Pharmaceutical include:
- Anticancer medications such as Paclitaxel, Carboplatin, and Docetaxel
- Cardiovascular medications such as Amlodipine, Lisinopril, and Metoprolol
- Neurology medications such as Gabapentin, Pregabalin, and Donepezil
- Respiratory medications such as Budesonide and Formoterol
- Gastroenterology medications such as Esomeprazole and Lansoprazole
- Antibiotics such as Ceftriaxone, Levofloxacin, and Azithromycin
- Pain management medications such as Tramadol and Diclofenac
- Vaccines such as Rabies vaccine and Hepatitis B vaccine
- Biosimilars such as Pegfilgrastim and Etanercept
Emcure Pharmaceutical is committed to developing innovative and affordable healthcare products that meet the needs of patients around the world. The company invests heavily in research and development to bring new and improved products to the market